(ACU7) Amundi Index Solutions - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU2059756598 • Europe Large-Cap Blend Equity

ACU7: Index Funds, Exchange Traded Funds, Sustainable Investments

Amundi Index Solutions - Amundi MSCI Europe SRI PAB UCITS ETF DR D (XETRA: ACU7) is a European large-cap blend equity ETF designed to track the performance of companies in developed Europe, incorporating ESG criteria. The fund is listed on XETRA, with a ticker symbol of ACU7, and is domiciled in Germany. It provides exposure to a market-capitalization-weighted index of large-cap companies in developed Europe, focusing on those that meet specific sustainability and ethical standards. The ETFs average daily trading volume over the past 20 days is 2,357 shares, with a last price of 68.76 EUR. The funds assets under management (AUM) stand at 127.73 million EUR, indicating moderate investor interest and liquidity. The ETFs technical indicators show a short-term SMA (20-day) of 69.69, a medium-term SMA (50-day) of 68.09, and a long-term SMA (200-day) of 67.36, suggesting a slightly bullish trend in recent weeks. The ATR (Average True Range) of 0.58 reflects relatively low volatility in the ETFs price movements.

Based on the provided and , the 3-month forecast for Amundi MSCI Europe SRI PAB UCITS ETF DR D (ACU7) is as follows: The ETF is expected to maintain its current trajectory, with potential upside driven by its exposure to large-cap European equities and ESG-focused investments. The SMA crossover (20-day SMA above 50-day SMA) indicates short-term bullish momentum, while the ATR suggests that price fluctuations will remain contained. The AUM of 127.73 million EUR indicates stable investor demand, supporting the ETFs liquidity. Overall, the ETF is likely to experience steady performance, with limited volatility, making it a conservative investment option for exposure to European large-cap equities with an ESG focus.

Additional Sources for ACU7 ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

ACU7 ETF Overview

Market Cap in USD 140m
Category Europe Large-Cap Blend Equity
TER 0.18%
IPO / Inception 2019-10-23

ACU7 ETF Ratings

Growth 5y 18.2%
Fundamental -
Dividend 57.4%
Rel. Strength -5.2
Analysts -
Fair Price Momentum 55.34 EUR
Fair Price DCF -

ACU7 Dividends

Dividend Yield 12m 2.31%
Yield on Cost 5y 2.39%
Annual Growth 5y 7.33%
Payout Consistency 98.3%

ACU7 Growth Ratios

Growth Correlation 3m -15.8%
Growth Correlation 12m 27.2%
Growth Correlation 5y 76.5%
CAGR 5y -0.77%
CAGR/Max DD 5y -0.03
Sharpe Ratio 12m 0.24
Alpha -8.58
Beta 0.570
Volatility 14.71%
Current Volume 4.8k
Average Volume 20d 2.1k
What is the price of ACU7 stocks?
As of April 08, 2025, the stock is trading at EUR 59.38 with a total of 4,795 shares traded.
Over the past week, the price has changed by -9.85%, over one month by -13.28%, over three months by -10.81% and over the past year by -8.12%.
Is Amundi Index Solutions a good stock to buy?
Neither. Based on ValueRay Analyses, Amundi Index Solutions is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 18.24 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ACU7 as of April 2025 is 55.34. This means that ACU7 is currently overvalued and has a potential downside of -6.8%.
Is ACU7 a buy, sell or hold?
Amundi Index Solutions has no consensus analysts rating.
What are the forecast for ACU7 stock price target?
According to ValueRays Forecast Model, ACU7 Amundi Index Solutions will be worth about 60.6 in April 2026. The stock is currently trading at 59.38. This means that the stock has a potential upside of +2.11%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 60.6 2.1%